Raman Bahal
Associate Professor/Pharmaceutical Science
Storrs Mansfield
Are you Raman Bahal?
How to update your information.
Scholarly Contributions
69 Scholarly Contributions
A universal discoidal nanoplatform for the intracellular delivery of PNAs.
2019
Research Type: Journal Article
Absorption, Distribution, Metabolism, and Excretion of US Food and Drug Administration–Approved Antisense Oligonucleotide Drugs
2022
Research Type: Journal Article
Advances in Nanoparticle-based Delivery of Next Generation Peptide Nucleic Acids.
2018
Research Type: Journal Article
Adverse Drug Reactions and Toxicity of the Food and Drug Administration–Approved Antisense Oligonucleotide Drugs
2022
Research Type: Journal Article
Anti-tumor Activity of miniPEG-γ-Modified PNAs to Inhibit MicroRNA-210 for Cancer Therapy.
2017
Research Type: Journal Article
Antisense Oligonucleotides: An Emerging Area in Drug Discovery and Development.
2020
Research Type: Journal Article
Antitumor effects of EGFR antisense guanidine-based peptide nucleic acids in cancer models.
2013
Research Type: Journal Article
Applications of PNA-laden nanoparticles for hematological disorders.
2019
Research Type: Journal Article
Composition of tunable carbohydrate nucleic acid conjugates for enhanced liver and kidney-specific targeting
2022
Research Type: Patent and Intellectual Property
Design of a "Mini" Nucleic Acid Probe for Cooperative Binding of an RNA-Repeated Transcript Associated with Myotonic Dystrophy Type 1.
2018
Research Type: Journal Article
Discoidal Nano Universal Platform for Efficient Delivery of PNAs for gene therapy based application
2019
Research Type: Patent and Intellectual Property
Discoidal nano universal platform for efficient delivery of PNAs
2023
Research Type: Patent and Intellectual Property
Dual-Modality Poly-l-histidine Nanoparticles to Deliver Peptide Nucleic Acids and Paclitaxel for In Vivo Cancer Therapy.
2021
Research Type: Journal Article
Dual-modality poly-L-histidine nanoparticles to deliver peptide nucleic acids and paclitaxel for in vivo cancer therapy
2022
Research Type: Patent and Intellectual Property
Effect of Steric Constraint at the γ-Backbone Position on the Conformations and Hybridization Properties of PNAs.
2011
Research Type: Journal Article
Evidence that miR-152-3p is a positive regulator of SETDB1-mediated H3K9 histone methylation and serves as a toggle between histone and DNA methylation
2020
Research Type: Journal Article